IL-1β induces tamoxifen resistance in the breast cancer cell model via prompting of Twist1 that propels methylation in the promoter region of the ESR1 gene which in turn reduces the expression of Erα [54]. The gene discussed is IL1B; the disease is breast carcinoma.